Celularity Inc.
NASDAQ: CELU0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert Joseph Hariri
- Employees
- 120
- Headquarters
- Florham Park, United States
- IPO year
- 2019
- Market cap
- $16.3M
- Website
- https://www.celularity.com
Loading CELU…
Loading profile data…Frequently asked questions about CELU
What does Celularity Inc. (CELU) do?
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s...
Where does CELU trade?
Celularity Inc. (CELU) trades on the NASDAQ Capital Market.
What sector is CELU in?
Celularity Inc. (CELU) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Celularity Inc.?
Robert Joseph Hariri is the chief executive officer of Celularity Inc. (CELU).
Where is Celularity Inc. headquartered?
Celularity Inc. is headquartered in United States.
Does CELU pay a dividend?
Celularity Inc. (CELU) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CELU go public?
Celularity Inc. (CELU) completed its initial public offering in 2019.